261 related articles for article (PubMed ID: 27450936)
1. Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?
Ambani SN; Morgan TM; Montgomery JS; Gadzinski AJ; Jacobs BL; Hawken S; Krishnan N; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Palapattu GS; Weizer AZ; Wolf JS
Urology; 2016 Dec; 98():88-96. PubMed ID: 27450936
[TBL] [Abstract][Full Text] [Related]
2. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.
McIntosh AG; Ristau BT; Ruth K; Jennings R; Ross E; Smaldone MC; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG
Eur Urol; 2018 Aug; 74(2):157-164. PubMed ID: 29625756
[TBL] [Abstract][Full Text] [Related]
3. Selecting Patients with Small Renal Masses for Active Surveillance: A Domain Based Score from a Prospective Cohort Study.
Sotimehin AE; Patel HD; Alam R; Gorin MA; Johnson MH; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
J Urol; 2019 May; 201(5):886-892. PubMed ID: 30694934
[TBL] [Abstract][Full Text] [Related]
4. Management of Renal Masses in an Octogenarian Cohort: Is There a Right Approach?
Tang DH; Nawlo J; Chipollini J; Gilbert SM; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
Clin Genitourin Cancer; 2017 Dec; 15(6):696-703. PubMed ID: 28566202
[TBL] [Abstract][Full Text] [Related]
5. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.
Salmasi A; Faiena I; Lenis AT; Pooli A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
Urol Oncol; 2018 Dec; 36(12):527.e13-527.e19. PubMed ID: 30228094
[TBL] [Abstract][Full Text] [Related]
6. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
Mason RJ; Abdolell M; Trottier G; Pringle C; Lawen JG; Bell DG; Jewett MA; Klotz L; Rendon RA
Eur Urol; 2011 May; 59(5):863-7. PubMed ID: 21353376
[TBL] [Abstract][Full Text] [Related]
7. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance of renal masses: an analysis of growth kinetics and clinical outcomes stratified by radiological characteristics at diagnosis.
Dorin R; Jackson M; Cusano A; Haddock P; Kiziloz H; Meraney A; Shichman S
Int Braz J Urol; 2014; 40(5):627-36. PubMed ID: 25498286
[TBL] [Abstract][Full Text] [Related]
9. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
10. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
11. Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis.
Tan WS; Trinh QD; Hayn MH; Marchese M; Lipsitz SR; Nabi J; Kilbridge KL; Vale JA; Khoubehi B; Kibel AS; Sun M; Chang SL; Sammon JD
Urol Oncol; 2020 Mar; 38(3):74.e13-74.e20. PubMed ID: 31864937
[TBL] [Abstract][Full Text] [Related]
12. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
13. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
14. Approach to the small renal mass: to treat or not to treat.
Kim SP; Thompson RH
Urol Clin North Am; 2012 May; 39(2):171-9, vi. PubMed ID: 22487760
[TBL] [Abstract][Full Text] [Related]
15. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma.
Song W; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
World J Urol; 2016 Jan; 34(1):83-8. PubMed ID: 25981404
[TBL] [Abstract][Full Text] [Related]
16. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
Uzosike AC; Patel HD; Alam R; Schwen ZR; Gupta M; Gorin MA; Johnson MH; Gausepohl H; Riffon MF; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
J Urol; 2018 Mar; 199(3):641-648. PubMed ID: 28951284
[TBL] [Abstract][Full Text] [Related]
17. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
18. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance.
Mehrazin R; Smaldone MC; Kutikov A; Li T; Tomaszewski JJ; Canter DJ; Viterbo R; Greenberg RE; Chen DY; Uzzo RG
J Urol; 2014 Sep; 192(3):659-64. PubMed ID: 24641909
[TBL] [Abstract][Full Text] [Related]
19. Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs).
Hawken SR; Krishnan NK; Ambani SN; Montgomery JS; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Kutikov A; Palapattu GS; Weizer AZ; Stuart Wolf J; Morgan TM
Urol Oncol; 2016 Nov; 34(11):486.e9-486.e15. PubMed ID: 27687544
[TBL] [Abstract][Full Text] [Related]
20. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
